Balaji Amines Limited (BALAMINES) AI Stock Analysis

• Market Cap: ₹32.54B
• Dividend Yield: 0.97%
• Average Volume (3M): 3.13K
• Price to Earnings (P/E): 29.5
• Beta (1Y): 1.18
• Revenue Growth: -10.76%
• EPS Growth: -27.70%
• Country: IN
• Employees: 1,084
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 12.20
• Shares Outstanding: 32,401,000
• 10 Day Avg. Volume: 2,179
• 30 Day Avg. Volume: 3,132
• PEG Ratio: -1.11
• Price to Book (P/B): 2.20
• Price to Sales (P/S): 2.91
• P/FCF Ratio: 46.43
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 41.45
• Revenue Forecast (FY): ₹13.64B

• Rating: 69 Neutral
• Price Target: ₹1,100.00 ▲(0.84% Upside)
• Action: Reiterated Date: 01/09/26
• Date: Action: Reiterated 01/09/26

The score is driven primarily by strong financial quality (low leverage and positive free cash flow), partially offset by mixed technicals (negative MACD and below longer-term moving averages) and a middling valuation (P/E 27.17 with a low ~0.90% dividend yield).

Positive Factors

Balance Sheet Strength

A conservatively leveraged balance sheet gives the company lasting financial flexibility to fund capex, weather demand downturns, and pursue selective downstream integration. Low leverage reduces refinancing risk and supports investment in higher-margin specialty chemistries over the medium term.

Cash Generation

Consistent positive free cash flow and healthy cash conversion underpin durable internal funding for maintenance capex, working capital and targeted growth initiatives. Reliable cash generation supports dividend capacity and lowers dependence on external financing.

Diversified End-Market Exposure & Downstream Mix

Serving multiple end markets and producing both base amines and higher-value downstream derivatives creates structural resilience. Downstream integration enables margin uplift, reduces reliance on raw amine commodity cycles, and broadens addressable markets over the medium term.

Negative Factors

Revenue Contraction

A multi-percent revenue decline signals demand pressure or market share challenges. If sustained, shrinking top-line constrains operating leverage, limits reinvestment capacity, and makes margin maintenance harder despite cash strength, affecting medium-term growth prospects.

Earnings Decline

A steep EPS decline indicates compressing profitability from mix shifts, cost pressures, or lower realizations. Continued erosion in per-share earnings can limit reinvestment, reduce stakeholder confidence, and make it harder to finance higher-margin moves without margin recovery.

Market Sensitivity / Cyclicality

Above‑1 beta and exposure to cyclic end markets imply earnings and cash flow remain sensitive to economic cycles and commodity swings. This structural volatility can complicate long-term planning, capital allocation and consistent margin expansion through business cycles.

Balaji Amines Limited Business Overview & Revenue Model

Company Description

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and CFL Lamps. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, and choline chloride; and pharma excipients, such as poly vinyl pyrrolidone. It serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, and water treatment chemical industries. In addition, the company operates Balaji Sarovar, a hotel in Solapur, Maharashtra; and manufactures and sells CFL lamps. It also exports its products to the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and internationally. The company was incorporated in 1988 and is based in Hyderabad, India.

How the Company Makes Money

Balaji Amines primarily makes money by manufacturing and selling chemicals (mainly aliphatic amines and their derivatives) to industrial customers. Revenue is generated through (1) sale of core amines (commodity-to-specialty intermediates) where volumes and realized prices drive topline, (2) sale of higher value-added amine derivatives and downstream/specialty products that typically carry different margin profiles than base amines, and (3) exports, where the same product portfolio is sold to international customers and revenues depend on global demand, realized export pricing, and currency movements. Its earnings are influenced by input/raw-material costs, plant utilization, and the extent of integration into downstream derivatives (which can shift the mix toward value-added products). Specific details such as customer concentration, named long-term offtake contracts, or disclosed strategic partnerships are not available in the provided prompt; null.

Balaji Amines Limited Financial Statement Overview

Summary

Overall financials are solid: a strong balance sheet with low leverage (82) and positive free cash flow with healthy cash conversion (79). Income statement performance is resilient (76), but recent revenue and net income contraction temper the score.

Income Statement

Balaji Amines has shown resilience in its income statement despite revenue fluctuations. The Gross Profit Margin and Net Profit Margin have been reasonably stable, reflecting effective cost management. However, the recent contraction in revenue and net income suggests challenges in market conditions or competition.

Balance Sheet

The balance sheet is strong, with a low Debt-to-Equity Ratio indicating conservative financial leverage. The equity ratio is robust, showcasing a solid capital structure. However, the company should watch for any increase in liabilities that could affect its financial stability.

Cash Flow

Cash flow metrics reveal effective cash management, with positive Free Cash Flow indicating the ability to sustain operations and investments. While the Operating Cash Flow to Net Income ratio is healthy, the company must focus on improving cash flow growth to support future expansions.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	13.64B	13.97B	16.08B	23.38B	23.20B	13.11B
Gross Profit	5.56B	4.88B	3.50B	8.39B	8.57B	5.39B
EBITDA	2.52B	2.65B	3.53B	6.24B	6.36B	3.79B
Net Income	1.46B	1.58B	2.05B	3.26B	3.68B	2.38B
Balance Sheet
Total Assets	23.31B	22.52B	21.46B	19.63B	18.75B	13.10B
Cash, Cash Equivalents and Short-Term Investments	1.86B	3.50B	3.31B	3.09B	515.37M	173.23M
Total Debt	314.46M	110.27M	196.97M	575.74M	1.01B	1.27B
Total Liabilities	2.75B	2.34B	2.53B	2.65B	5.60B	4.00B
Stockholders Equity	18.82B	18.45B	17.22B	15.54B	12.50B	8.94B
Cash Flow
Free Cash Flow	-1.62B	874.82M	704.14M	2.62B	842.07M	-221.07M
Operating Cash Flow	222.05M	2.73B	3.34B	3.82B	2.32B	1.10B
Investing Cash Flow	-1.15B	-1.61B	-1.64B	-1.86B	-1.47B	-615.89M
Financing Cash Flow	-169.00M	-447.73M	-749.66M	-812.33M	-565.13M	-374.51M

Balaji Amines Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1090.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BALAMINES, the sentiment is Negative. The current price of 1090.8 is above the 20-day moving average (MA) of 1047.97, below the 50-day MA of 1111.27, and below the 200-day MA of 1350.88, indicating a bearish trend. The MACD of -21.98 indicates Negative momentum. The RSI at 42.38 is Neutral, neither overbought nor oversold. The STOCH value of 53.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BALAMINES.

Balaji Amines Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BALAMINES	69 Neutral	₹32.54B	29.53	―	0.97%	-10.76%	-27.70%
ANURAS	64 Neutral	₹141.43B	76.50	―	0.06%	69.32%	113.55%
ROSSARI	64 Neutral	₹21.45B	24.59	―	0.09%	15.47%	-1.72%
ALKYLAMINE	62 Neutral	₹63.39B	48.28	―	0.62%	3.95%	8.28%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
NEOGEN	61 Neutral	₹32.98B	211.46	―	0.09%	8.44%	-35.59%
FAIRCHEMOR	46 Neutral	₹5.85B	-2,425.33	―	1.07%	-22.10%	-85.56%

Balaji Amines Limited Corporate Events

Balaji Amines Opens Special Window for Transfer and Demat of Physical Shares

Balaji Amines Limited has announced that it has published newspaper advertisements in The Indian Express and Lokmat regarding a special window for the transfer and dematerialisation of physical shares. The move reflects the company’s ongoing compliance with SEBI Listing Regulations and supports the broader transition toward dematerialised holdings, potentially improving ease of share transfer and transparency for its investors.

The company has also informed that the details of this special window and related disclosures are available on its official website. By proactively communicating through multiple channels, Balaji Amines aims to ensure that shareholders holding physical share certificates are aware of the opportunity to convert to demat form, aligning with market-wide efforts to modernise and secure shareholding records.